Source 1primary paper2026MED
Toolkit/BMV9
BMV9
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
BMV9 (spo0A3; abrB*; 94manPA; sfp+) is, to date, the highest surfactin producer reported scientifically.
Usefulness & Problems
Why this is useful
BMV9 is an engineered Bacillus subtilis strain used as a high-level surfactin producer. The abstract presents it as a benchmark high-producer for comparing media effects and downstream application potential.; high surfactin production; comparing culture-medium effects on lipopeptide production
Source:
BMV9 is an engineered Bacillus subtilis strain used as a high-level surfactin producer. The abstract presents it as a benchmark high-producer for comparing media effects and downstream application potential.
Source:
high surfactin production
Source:
comparing culture-medium effects on lipopeptide production
Problem solved
It addresses the need for a strong microbial chassis for economically viable surfactin production and application testing.; provides an engineered Bacillus subtilis high-producer strain for surfactin production studies
Source:
It addresses the need for a strong microbial chassis for economically viable surfactin production and application testing.
Source:
provides an engineered Bacillus subtilis high-producer strain for surfactin production studies
Problem links
provides an engineered Bacillus subtilis high-producer strain for surfactin production studies
LiteratureIt addresses the need for a strong microbial chassis for economically viable surfactin production and application testing.
Source:
It addresses the need for a strong microbial chassis for economically viable surfactin production and application testing.
Published Workflows
Objective: Compare two engineered Bacillus subtilis surfactin high-producer strains across culture media to identify conditions supporting economically viable surfactin production and to assess agricultural and petrochemical application potential.
Why it works: The study combines controlled medium comparison during fermentation with analytical quantification and downstream application assays so that production performance can be linked to both lipopeptide composition and practical use cases.
surfactin productionfengycin productionantifungal activity of lipopeptide-containing preparationsoil displacement by surfactinshake-flask fermentationculture-medium comparisonHPTLC quantificationLC-MS/MS characterizationantifungal testingoil displacement testing
Stages
- 1.Shake-flask fermentation under two media conditions(functional_characterization)
This stage establishes how the two engineered strains perform under different nutrient conditions before downstream application testing.
Selection: compare strain performance and nutrient effects on surfactin yield in mineral salt versus complex medium, each with 2% glucose
- 2.Time-course lipopeptide quantification and cultivation monitoring(secondary_characterization)
This stage provides analytical and process readouts needed to compare strains and media over time.
Selection: quantify surfactin and fengycin and monitor optical density, residual glucose, and pH throughout cultivation
- 3.Small-scale growth validation(confirmatory_validation)
This stage confirms growth behavior observed in the main cultivation comparison.
Selection: validate microbial growth in both media using small-scale cultivation approaches
- 4.Agricultural antifungal testing(confirmatory_validation)
This stage evaluates whether the produced lipopeptides have practical biocontrol activity against soybean phytopathogens.
Selection: test culture supernatants and lipopeptide extracts against two Diaporthe species
- 5.Petrochemical oil displacement testing(confirmatory_validation)
This stage tests whether the produced surfactin shows function relevant to enhanced oil recovery and related uses.
Selection: evaluate surfactin efficacy in oil displacement tests relevant to enhanced oil recovery, bioremediation, and related petrochemical processes
- 6.LC-MS/MS lipopeptide characterization(secondary_characterization)
This stage adds structural and compositional detail to the production and application comparisons.
Selection: structurally characterize and relatively quantify lipopeptides by high-resolution LC-MS/MS
Steps
- 1.Cultivate BMV9 and BsB6 in shake flasks with mineral salt or complex medium supplemented with 2% glucoseengineered producer strains under comparison
Generate biomass and lipopeptides under defined media conditions for comparative analysis.
Cultivation is required before any production, growth, or application measurements can be made.
- 2.Extract lipopeptides and quantify surfactin and fengycin at multiple time points by HPTLC while monitoring optical density, residual glucose, and pHquantification assay
Measure production dynamics and cultivation state across strains and media.
Analytical monitoring follows cultivation so the authors can compare output and process behavior over time.
- 3.Validate microbial growth in both media using small-scale cultivation approaches
Confirm growth behavior observed in the main cultivation experiments.
This confirmatory step follows the main fermentation measurements to validate growth observations across media.
- 4.Test culture supernatants and lipopeptide extracts against two Diaporthe species
Assess agricultural biocontrol potential of the produced lipopeptides.
Application testing is performed after production samples are available from fermentation and extraction.
- 5.Perform oil displacement tests to evaluate surfactin efficacy for enhanced oil recovery, bioremediation, and related petrochemical processes
Assess petrochemical application potential of surfactin-containing preparations.
This downstream application assay uses produced surfactin after fermentation and extraction workflows have generated material to test.
- 6.Use high-resolution LC-MS/MS to structurally characterize and relatively quantify the lipopeptidesstructural characterization assay
Define lipopeptide structural profiles and relative abundance patterns associated with the compared strains and media.
This analytical step follows production and application testing to provide deeper compositional interpretation of the observed outputs.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Mechanisms
microbial biosynthesisTechniques
No technique tags yet.
Target processes
No target processes tagged yet.
Input: Chemical
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator
Use requires Bacillus subtilis fermentation in shake flasks with mineral salt or complex medium supplemented with 2% glucose, plus lipopeptide extraction and analytical assays such as HPTLC and LC-MS/MS.; requires the specified engineered genotype spo0A3; abrB*; 94manPA; sfp+; evaluated under shake-flask fermentation with defined media conditions
The abstract does not show that BMV9 alone solves scale-up, purification, or field-deployment challenges beyond the tested shake-flask and application assays.; application performance and optimal conditions are only described as being evaluated in this study
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Lipopeptides from the engineered Bacillus subtilis strains were evaluated for agricultural antifungal activity against two Diaporthe species and for oil displacement relevant to petrochemical applications.
High-resolution LC-MS/MS enabled structural characterization and relative quantification of the lipopeptides.
HPTLC was used to quantify surfactin and fengycin at multiple time points up to 48 hours.
time course duration 48 h
BMV9 is described as the highest surfactin producer reported scientifically.
BsB6 is an sfp+ laboratory derivative strain with considerable surfactin production potential.
Approval Evidence
1 source2 linked approval claimsfirst-pass slug bmv9
BMV9 (spo0A3; abrB*; 94manPA; sfp+) is, to date, the highest surfactin producer reported scientifically.
Source:
application potentialsupports
Lipopeptides from the engineered Bacillus subtilis strains were evaluated for agricultural antifungal activity against two Diaporthe species and for oil displacement relevant to petrochemical applications.
Source:
performancesupports
BMV9 is described as the highest surfactin producer reported scientifically.
Source:
Comparisons
Source-stated alternatives
The paper contrasts BMV9 with another engineered strain, BsB6, as an alternative surfactin-producing Bacillus subtilis background.
Source:
The paper contrasts BMV9 with another engineered strain, BsB6, as an alternative surfactin-producing Bacillus subtilis background.
Source-backed strengths
described as the highest surfactin producer reported scientifically
Source:
described as the highest surfactin producer reported scientifically
Compared with BsB6
The paper contrasts BMV9 with another engineered strain, BsB6, as an alternative surfactin-producing Bacillus subtilis background.
Shared frame: source-stated alternative in extracted literature
Strengths here: described as the highest surfactin producer reported scientifically.
Relative tradeoffs: application performance and optimal conditions are only described as being evaluated in this study.
Source:
The paper contrasts BMV9 with another engineered strain, BsB6, as an alternative surfactin-producing Bacillus subtilis background.
Ranked Citations
- 1.